Suppr超能文献

住院孕妇接触医疗设备中含有的增塑剂。

Exposure of hospitalised pregnant women to plasticizers contained in medical devices.

作者信息

Marie Cécile, Hamlaoui Sebti, Bernard Lise, Bourdeaux Daniel, Sautou Valérie, Lémery Didier, Vendittelli Françoise, Sauvant-Rochat Marie-Pierre

机构信息

Axe TGI-PEPRADE, Institut Pascal, Sigma Clermont, CNRS, Université Clermont Auvergne, 63001, Clermont-Ferrand, France.

Service biostatistique, Pôle Santé Publique, CHU de Clermont-Ferrand, 63003, Clermont-Ferrand, France.

出版信息

BMC Womens Health. 2017 Jun 20;17(1):45. doi: 10.1186/s12905-017-0398-7.

Abstract

BACKGROUND

Medical devices (MDs) in polyvinyl chloride (PVC) are not a well-known source of exposure to plasticizers, in particular during pregnancy. Because of its toxicity, the di-(2-ethylhexyl) phthalate (DEHP) has been replaced by other plasticizers such as di (isononyl)-cyclohexane-1,2-dicarboxilic acid (DINCH), tri-octyltrimellitate (TOTM) and di-(isononyl) phthalate (DiNP). Our study aimed to quantify the plasticizers (DEHP and alternative plasticizers) contained in PVC medical devices used for hospitalised pregnant women and to describe which these MDs had been used (type, number, duration of exposure).

METHODS

The plasticizers contained in the MDs used for daily care in the Obstetrics Department of a French University Hospital were extracted from PVC (after contact with a chloroform solution), identified and quantified by gas-chromatography-mass-spectrometry analysis. A total of 168 pregnant women hospitalised in the Obstetrics Department with at least one catheter were included in the observational study. The median number of MDs containing plasticizers used and the daily duration of exposure to the MDs were compared in three groups of pregnant women: "Pathology group" (women hospitalised for an obstetric disorder who did not give birth during this hospitalisation; n = 52), "Pathology and delivery group" (hospitalised for an obstetric disorder and who gave birth during this stay; n = 23) and "Delivery group" (admitted for planned or spontaneous delivery without obstetric disorder; n = 93).

RESULTS

DiNP, TOTM and DINCH were the predominant plasticizers contained in the MDs at an amount of 29 to 36 g per 100 g of PVC. Women in the "Pathology group" (preterm labour or other pathology) were exposed to a median number of two MDs containing TOTM and one MD containing DiNP, fewer than those in the "Pathology and delivery group" (p < 0.05). Women in the "Pathology group" had a median exposure of 3.4 h/day to MDs containing DiNP and 8.2 h/day to MDs containing TOTM, longer than those in the "Delivery group" (p < 0.01).

CONCLUSIONS

Our study shows that the medical management of pregnant women in a hospital setting entails exposure to MDs containing alternative plasticizers (DiNP, TOTM and DINCH).

摘要

背景

聚氯乙烯(PVC)材质的医疗器械并非广为人知的增塑剂暴露源,尤其是在孕期。由于邻苯二甲酸二(2-乙基己基)酯(DEHP)具有毒性,已被其他增塑剂所取代,如双(异壬基)环己烷-1,2-二羧酸酯(DINCH)、偏苯三酸三辛酯(TOTM)和邻苯二甲酸二(异壬基)酯(DiNP)。我们的研究旨在量化用于住院孕妇的PVC医疗器械中所含的增塑剂(DEHP和替代增塑剂),并描述使用了哪些医疗器械(类型、数量、暴露持续时间)。

方法

从法国一家大学医院妇产科日常护理所用医疗器械的PVC中提取增塑剂(与氯仿溶液接触后),通过气相色谱-质谱分析进行鉴定和定量。共有168名在妇产科住院且至少使用过一根导管的孕妇纳入观察性研究。比较了三组孕妇使用含增塑剂医疗器械的中位数数量和每日暴露时长:“病理组”(因产科疾病住院且此次住院期间未分娩的女性;n = 52)、“病理与分娩组”(因产科疾病住院且此次住院期间分娩的女性;n = 23)和“分娩组”(因计划内或自然分娩入院且无产科疾病的女性;n = 93)。

结果

DiNP、TOTM和DINCH是医疗器械中所含的主要增塑剂,每100克PVC中含量为29至36克。“病理组”(早产或其他疾病)的女性接触含TOTM的医疗器械中位数数量为两个,含DiNP的医疗器械为一个,少于“病理与分娩组”(p < 0.05)。“病理组”的女性每日接触含DiNP医疗器械的时长中位数为3.4小时,接触含TOTM医疗器械的时长中位数为8.2小时,长于“分娩组”(p < 0.01)。

结论

我们的研究表明,医院环境中对孕妇的医疗管理会导致接触含替代增塑剂(DiNP、TOTM和DINCH)的医疗器械。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e12/5480197/22396b1ec965/12905_2017_398_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验